NCT01408602: A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients |
|
|
| Unknown status | 2 | 300 | US | MRC375, Matching Placebo, MRC375 150mg | Molecular Research Center, Inc., Camargo Pharmaceutical Services, Clin Data Services, Harrison Clinical Research, BARC Global Central Laboratory, Bilcare Global Clinical Supplies | Rheumatoid Arthritis | 07/14 | 07/14 | | |